Market Research Reports, Business Consulting Services & Analytics

The Increasing Prevalence Of Autoimmune Diseases Boost the Antinuclear Antibody Market

HYDERABAD, TELANGANA, INDIA, November 10, 2022 /EINPresswire.com/ -- IndustryARC, in its latest report, predicts that the Antinuclear Antibody Market size is estimated at $1.3 billion in 2020, projected to grow at a CAGR of 12.3% during the forecast period 2021-2026. The Antinuclear Antibody (ANA) is a class of auto antibodies produced by a person's immune system. Antinuclear antibody testing is majorly utilized to understand the auto-immune conditions including Systemic lupus erythematosus and rheumatoid arthritis. According to a study by the Foundation for Peripheral Neuropathy, Guillain-Barre Syndrome (GBS) affected 3,000-6,000 people in the United States each year in 2019. As a result, the demand for early screening for successful care is projected to increase as the target patient base grows. The report offers a complete analysis of the market, its major segments, growth factors, trends, drivers and challengers, key players and more.

Click here to browse the complete report summary:
https://www.industryarc.com/Research/Antinuclear-Antibody-Market-Research-508521

Key Takeaways:

This IndustryARC report on the Antinuclear Antibody Market highlights the following areas -

1. Antinuclear antibody (ANA) market growth is being driven by technological advances, adoption of new techniques, and the prevalence of various autoimmune diseases.

2. Geographically, North America Antinuclear Antibody Market held the largest revenue share of 36% in 2020 owing to the involvement of potential players who are developing innovative products, advances in medical device technology, high investments in R&D and support of government. In the final report, the scope of the Antinuclear Antibody Market for various regions will be given.

3. The Antinuclear Antibody Industry is expanding owing to enhanced R&D efforts by companies to develop quick, cost-effective, and new technology-based Antinuclear Antibody for the treatment of Rheumatoid Arthritis.

4. Infections caused by the Epstein–Barr virus, Campylobacter jejuni, and other bacteria are also expected to push the Antinuclear Antibody industry.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=508521

Segmental Analysis:

Antinuclear Antibody Market Segment Analysis - By Test Type: Clinical preference grew as a result of the highly sensitive and fast test results compared to other techniques. Furthermore, their ability to recognize different patterns, such as nucleolar, speckled, and homogeneous, Systemic lupus erythematosus which indicate autoantibodies linked to diseases, is fueling the segment's development and is expected to drive market growth.

Antinuclear Antibody Market Segment Analysis – Disease Indication: Rheumatoid Arthritis is basically a inflammatory ailment which affects the eyes, skin, lungs, blood vessels and heart. When a patient's immune system attacks its own body's tissues, this disease develops. Arthritis affects about one out of every three people aged 18 to 64, according to the Arthritis Foundation.

Antinuclear Antibody Market Segment Analysis - By Geography: Asia-Pacific is predicted to be the fastest growing region during the forecast period 2021- 2026 owing towards presence of a large elderly population, increasing disposable income, and rising awareness about these procedures also owing to differing regulatory factors, the market is highly diverse, resulting in differences in product availability across region.

Competitive Landscape:

The top 5 players in the Antinuclear Antibody industry are -

1. Thermo Fisher Scientific, Inc.

2. F. Hoffmann-La Roche Ltd.

3. Antibodies, Inc.

4. Inova Diagnostics

5. Zeus Scientific, Inc.

Click on the following link to buy the Antinuclear Antibody Market report:
https://www.industryarc.com/reports/request-quote?id=508521

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website, but also get personalized assistance on specific reports.

Similar Reports:

A. Medical Devices Reimbursement Market
https://www.industryarc.com/Report/19500/medical-devices-reimbursement-market.html

B. Antibody Production Market
https://www.industryarc.com/Research/Antibody-Production-Market-Research-504143

Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+ +1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.